Adverse events and problems in therapeutic hemapheresis. A report from the Swedish registry

Transfusion and Apheresis Science

Volumn 25, Issue 1, 2001, Pages 33-41

  Norda, R ^a   Berseus O ^b   Stegmayr, B ^c  

^a ÖREBRO MEDICAL CENTRE HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adverse events; Apheresis; Hematopoietic progenitor cell collection; Immunoadsorption; National registry; Photopheresis; Plasma exchange; Plasmapheresis

Indexed keywords

APHERESIS; ARTICLE; COMPLICATION; CYTAPHERESIS; GOODPASTURE SYNDROME; GUILLAIN BARRE SYNDROME; HEMATOPOIETIC STEM CELL; HUMAN; HYPOTENSION; IMMUNOADSORPTION; NAUSEA; PARESTHESIA; PLASMAPHERESIS; PUVA; REGISTER; SHIVERING; SWEDEN; THROMBOTIC THROMBOCYTOPENIC PURPURA; URTICARIA;

AUTOIMMUNE DISEASES; DISEASE SUSCEPTIBILITY; EXTRACORPOREAL CIRCULATION; FLUSHING; HEMATOLOGIC DISEASES; HUMANS; HYPOTENSION; IMMUNOSORBENT TECHNIQUES; INCIDENCE; NAUSEA; NEOPLASMS; PARESTHESIA; PLASMA EXCHANGE; PLASMAPHERESIS; REGISTRIES; SEVERITY OF ILLNESS INDEX; SWEDEN; URTICARIA;

EID: 0035187258     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-0502(01)00079-9     Document Type: Article

References (30)

1. Therapeutic apheresis in hematological and oncological diseases
2. Spin doctors: new innovations for centrifugal apheresis
3. Plasmapheresis in the critically ill patient
4. Plasmapheresis and immunoadsorption: different techniques and their current role in medical therapy
5. Frequency of immediate adverse effects associated with apheresis donation
6. Frequency of immediate adverse effects associated with therapeutic apheresis
7. Introduction to the third special issue: clinical applications of therapeutic apheresis
8. The Canadian apheresis group and therapeutic plasma exchange
9. Plasmapheresis in the treatment of glomerulonephritis: indications and complications
10. Severe infections in plasmapheresis-treated systemic lupus erythematosus
11. Prevention of citrate reactions during therapeutic plasma exchange by constant infusion of calcium gluconate with the return fluid
12. On the use of liquid stored or cryoprecipitate-poor plasma in plasma exchange
13. Role of replacement fluids in the immediate complications of plasma exchange. French Registry Cooperative Group
14. Clinically relevant hypokalaemia, hypocalcaemia, and loss of hemoglobin and platelets during stem cell apheresis
15. Apheresis registry in France: indications, techniques, and complications. French Registry Study Group (in process citation)
16. Therapeutic plasma exchange: an update from the Canadian apheresis group
17. Three years with a national apheresis registry
18. National survey of hemapheresis practice in Turkey 1998
19. Present status of therapeutic apheresis in Japan: survey report (Survey Subcommittee, Scientific Committee, Japanese Society for Apheresis)
20. A preliminary survey of the apheresis activity in Italy: a perspective for the Italian registry of apheresis
21. Apheresis registry in Sweden: scope, techniques and indications for treatment. A report from the Swedish apheresis study group
22. Complications of plasma exchange
23. Comparison of the side effects of therapeutic cytapheresis and those of other types of hemapheresis
24. Pentastarch as partial replacement fluid for therapeutic plasma exchange: effect on plasma proteins, adverse events during treatment, and serum ionized calcium
25. Anaphylactoid reactions, LDL apheresis with dextran sulphate, and ACE-inhibitors (letter)
26. Hypotension during sham apheresis in a patient taking ACE-inhibitors (letter)
27. Apheresis and ACE inhibitors
28. Safety of plasmapheresis in the treatment of neurological disease